Late Arrhythmias in Patients with New-Onset Persistent Left Bundle Branch Block After Transcatheter Aortic Valve Replacement Using a Balloon-Expandable Valve.
外科
主动脉瓣
作者
Guillem Muntané-Carol,Luis Nombela-Franco,Vicenç Serra,Marina Urena,Ignacio J. Amat-Santos,Victoria Vilalta,Chekrallah Chamandi,Thibault Lhermusier,Gabriela Veiga-Fernandez,Neal S. Kleiman,Victoria Cañadas-Godoy,Jaume Francisco-Pascual,Dominique Himbert,Javier Castrodeza,Eduard Fernandez-Nofrerias,Pierre Baudinaud,Pierre Mondoly,Francisco Campelo-Parada,José M. de la Torre Hernández,Emilie Pelletier-Beaumont,François Philippon,Josep Rodés-Cabau
Background The arrhythmic burden after discharge in patients with new-onset left bundle branch block (LBBB) undergoing transcatheter aortic valve replacement (TAVR) with the balloon-expandable SAPIEN 3 (S3) valve remains largely unknown. Objective The purpose of this study was to determine the incidence of late arrhythmias in patients with new-onset LBBB undergoing TAVR with the balloon-expandable S3 valve. Methods This was a multicenter, prospective study that included 104 consecutive TAVR patients with new-onset persistent LBBB following TAVR with the S3 valve. An implantable cardiac monitor (Reveal XT, Reveal LINQ) was implanted before discharge. The primary endpoint was the incidence of high-degree atrioventricular block or complete heart block (HAVB/CHB). Results A total of 40 patients (38.5%) had at least 1 significant arrhythmic event, leading to a treatment change in 17 (42.5%). Significant bradyarrhythmias occurred in 20 of 104 patients (19.2%) (34 HAVB/CHB episodes, 252 severe bradycardia episodes), with 10 of 20 patients (50%) exhibiting at least 1 episode of HAVB/CHB. Most HAVB/CHB episodes (60%) occurred within 4 weeks after discharge. Nine patients (8.7%) underwent permanent pacemaker implantation at 12 months based on the Reveal findings (6 HAVB/CHB, 3 severe bradycardia). Conclusion S3 valve recipients with new-onset LBBB have a high arrhythmic burden, with more than one-third of patients exhibiting at least 1 significant arrhythmic episode within 12 months (HAVB/CHB in 10% of patients). About one-half of bradyarrhythmic events occurred within 4 weeks after discharge. These results should inform future strategies on the use of continuous electrocardiographic monitoring in TAVR S3 patients with new conduction disturbances following the procedure.